Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Bernd Liphardt has worked on the following 18 EPO patent applications which have been published in the last five years:

EP12788585

ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES

IPC classification:
A61K 31/42, A61P 33/00
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12707629

ISOXAZOLE DERIVATIVES

IPC classification:
A01N 43/80, A01N 47/38, C07D 413/04, C07D 413/14, C07D 417/14, C07D 419/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 51/28, B65D 81/32
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 31/17, A61P 33/14
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP11728632

ANTIBIOTIC COMPOSITIONS

IPC classification:
A61K 9/19, A61K 31/7048, A61P 31/04, A61P 33/02
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION REQUESTED
EP11715238

ORAL DOSAGE FORMS

IPC classification:
A61K 9/70, A61K 31/465
Applicant:
Novartis AG
Agent:
Bernd Liphardt, Novartis AG
Agent:
Bernd Liphardt, Novartis Consumer Health SA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13739444

NEW TREATMENT OF FISH WITH A NANOSUS PENS ION OF LUFENURON OR HEXAFLUMURON

IPC classification:
A01N 47/34, A61K 9/00, A61K 9/14, A61K 31/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13747376

SUBTITUTED AZINES AS PESTICIDES

IPC classification:
A01N 43/54, A01P 17/00, A61K 31/505, A61K 31/506, C07D 213/74, C07D 239/47, C07D 239/48, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 403/14, C07D 413/14, C07D 487/10
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14162391

Aminosulfonylmethylcyclohexanes as JAK inhibitors

IPC classification:
A61K 31/44, A61K 31/50, A61K 31/505, A61K 31/52, C07D 239/46, C07D 471/04, C07D 471/14, C07D 473/34, C07D 487/04, C07D 495/04
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 37/18, A01N 43/04, A01N 43/08, A01N 43/10, A01N 43/40
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14172659

New compounds

IPC classification:
A01N 41/06, A01N 43/36, A01N 43/40, A01N 43/54, A01N 43/78, C07C 311/08, C07D 207/335, C07D 213/643, C07D 239/34, C07D 277/66
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP14182960

ANTHRANILAMIDES, SULFONAMIDES AND NITRO ANALOGUES DERIVED THEREFROM AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 205/11, C07C 311/08, C07C 311/20, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP11725453

5-ARYL ISOXAZOLINES FOR CONTROLLING PESTS

IPC classification:
A01N 43/80, C07D 413/04, C07D 413/14, C07D 417/14
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11764133

NOVEL PROCESS FOR THE PREPARATION OF 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A MODIFIED IN THE C-4'' OF THE CLADINOSE RING BY AN EPOXIDE GROUP

IPC classification:
C07H 1/00, C07H 17/08
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11709952

ENDOPARASITICIDAL COMPOSITIONS

IPC classification:
A01N 37/34, A01N 43/90, A61K 31/277, A61P 33/00
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP12704256

ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS

IPC classification:
A01N 43/84, A01N 47/24
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature